Hjem › Parkinsons sygdom › Arkansas
Parkinsons sygdom kliniske forsøg i Arkansas
5 studier for Parkinsons sygdom søger deltagere på steder i Arkansas.
Byer i Arkansas
Officiel studietekst (engelsk)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Arkansas, Little Rock
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Arkansas for Medical Sciences (Site #208), Little Rock
RekruttererFase 2
Alder 30 til 80 · Alle køn · Opdateret 10. sep. 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Arkansas, Fayetteville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04994015A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 3
Alder 45 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06944522A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2025 · NCT06765668Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.